Hepatitis B Virus Infection and Beyond: Viral Coinfections, Metabolic Risk, and the Evolving Pathway to Hepatocellular Carcinoma
Nov
2026
Description
Developed by the Patient Advisory Group, this session explores important topics affecting persons living with hepatitis B virus (HBV) infection, including:
Hepatocellular carcinoma (HCC) surveillance
New American Association for the Study of Liver Diseases HBV guidelines
Emerging diseases such as hepatitis D virus and Met-HBV
Unique challenges of treating chronic hepatitis B and coinfections
Barriers to surveillance and treatment
Presentations
8:00 AM
- 8:15 AM
Convention Center - Mile High Ballroom 4DEF
Staying Ahead of Liver Cancer: New Screening Recommendations
Amy S Tang, MD | Presenter
8:15 AM
- 8:30 AM
Convention Center - Mile High Ballroom 4DEF
When Viruses Collide: Navigating Hepatitis B With Hepatitis C, Hepatitis D, and Human Immunodeficiency Virus
Carla S Coffin | Presenter
8:30 AM
- 8:45 AM
Convention Center - Mile High Ballroom 4DEF
What Is Met-HBV? A New Diagnosis Patients and Providers Should Know About
Joseph K. Lim, MD, FAASLD | Presenter
8:45 AM
- 9:15 AM
Convention Center - Mile High Ballroom 4DEF
Living With Hepatitis B and Hepatitis D: What Patients Face in Treatment and Monitoring
Ravshan Yakubov, MBA, CPA, CA | Presenter
9:15 AM
- 9:30 AM
Convention Center - Mile High Ballroom 4DEF
Panel Discussion
Jacki Chen | Moderator
